Brief: Destiny Pharma Reports Efficacy Of XF-70 In Fungal Skin Infections
18/06/2024 07:23
June 18 (Reuters) - Destiny Pharma PLC DEST.L :
* EFFICACY OF XF-70 IN FUNGAL SKIN INFECTIONS
* XF-70 DEMONSTRATED POTENCY IN AN IN VIVO MODEL OF RINGWORM
* XF-70 RECORDED ANTI-FUNGAL EFFICACY OF 94.9% AT HIGHEST
CONCENTRATION TESTED
Source text for Eikon: ID:nRSR7809Sa
Further company coverage: DEST.L
((Reuters.Briefs@thomsonreuters.com;))